Kancera
  • Svenska
  • Home
  • About us
    • Statement from the CEO
    • Business model
    • Management
    • Board of directors
  • Research&Development
    • R&D portfolio
    • Fractalkine project
      • The problem
      • The solution
      • This is how KAND567 works
      • Next step
      • The future
    • Scientific publications
  • Investors
    • The share
    • Press releases
    • Reports
      • Principles and definitions
    • Calendar
    • Corporate Governance
      • Articles of association
      • General meeting
      • Board of directors committee
      • Board of directors
      • CEO and management
      • Auditors
    • Subscribe
  • Press
    • Press releases
    • Images and logos
    • Subscribe
    • News
    • Press contact
  • Contact
    • Careers
Select Page

Interim report for the third quarter 2020, January 1st – September 30th, 2020

by | Nov 20, 2020

Third quarter in brief as well as the period 1 January – 30 September 2020Net sales for the period (January to September) amounted to SEK 0,09 million (3,3 million), of which the third quarter contributed SEK 0,05 million (0,20 million).R&D costs for the period...

Delårsrapport för tredje kvartalet 2020, 1 januari – 30 september 2020

by | Nov 20, 2020

Tredje kvartalet i korthet samt perioden 1 januari – 30 september 2020Nettoomsättningen för perioden (januari till september) uppgick till 0,09 Mkr (3,3 Mkr), varav tredje kvartalet utgjorde 0,05 Mkr (0,20 Mkr).FoU-kostnader för perioden uppgick till 28,1 Mkr (27,5...

Interim report for the third quarter 2019, 1 January – 30 September 2019

by kancerawebedit | Nov 26, 2019

Third quarter in brief 1 July – 30 September 2019 Net sales for the period (January to September) amounted to SEK 3,3 Million (0,1 Million) of which the third quarter contributed SEK 0,2 Million (0,0 Million). R&D costs for the period amounted to SEK 27,5 Million...

Delårsrapport för tredje kvartalet 2019, 1 januari – 30 september 2019

by kancerawebedit | Nov 22, 2019

Tredje kvartalet i korthet 1 juli – 30 september 2019 Nettoomsättning för perioden (januari till september) uppgick till 3,3 Mkr (0,1 Mkr) varav tredje kvartalet utgjorde 0,2 Mkr (0,0 Mkr). FoU-kostnader för perioden uppgick till 27,5 Mkr (31,3 Mkr) varav tredje...

INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th September 2018

by kancerawebedit | Nov 23, 2018

PERIOD JAN – SEPTEMBER 2018, AND THIRD QUARTER IN BRIEF • Net sales for the period (January to September) amounted to SEK 0.1 million (SEK 0.1 million) of which the third quarter amounted to SEK 0.1 million (SEK 0.0 million). • R&D expenses for the period...
« Older Entries

Swedish

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

     

    Download our reports here

    Read all press releases

    Check out the latest news

    Click on the image to download our latest report

    Kancera AB

    Karolinska Institutet Science Park
    Nanna Svartz Väg 4
    SE-171 65 Solna, Sweden
    Tel: +46 (0)850 12 60 80

    This site uses cookies. Follow the link below for more information and our web policy:
    • Website policy
    • Svenska
    Copyright 2017 Kancera AB